| Identification | Back Directory | [Name]
1H-Indazole-3-carboxamide, N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(4-penten-1-yl)- | [CAS]
2666932-44-9 | [Synonyms]
1H-Indazole-3-carboxamide, N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(4-penten-1-yl)- | [Molecular Formula]
C19H26N4O2 | [MOL File]
2666932-44-9.mol | [Molecular Weight]
342.44 |
| Chemical Properties | Back Directory | [Boiling point ]
592.4±40.0 °C(Predicted) | [density ]
1.16±0.1 g/cm3(Predicted) | [solubility ]
DMF: 12 mg/ml
DMSO: 12 mg/ml
DMSO: PBS (pH 7.2) (1:8): 0.1 mg/ml
Ethanol: 10 mg/ml | [pka]
11.45±0.46(Predicted) |
| Hazard Information | Back Directory | [Description]
ADB-4en-PINACA (Item No. 33205) is an analytical reference standard categorized as a synthetic cannabinoid.1 ADB-4en-PINACA is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | [References]
[1] KATHARINA ELISABETH GRAFINGER. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays[J]. Drug Testing and Analysis, 2021, 13 7: 1412-1429. DOI: 10.1002/dta.3054 |
|
|